搜索临床试验以:ALIMTA
总计372个结果
-
AstraZeneca完全的
-
University of Southern CaliforniaNational Cancer Institute (NCI)完全的
-
National Guard Health Affairs终止
-
Dartmouth-Hitchcock Medical CenterCTI BioPharma完全的
-
Eli Lilly and Company完全的
-
Rongjie TaoNational Natural Science Foundation of China未知中枢神经系统肿瘤
-
Eli Lilly and Company完全的
-
Eli Lilly and Company完全的
-
University of PittsburghBristol-Myers Squibb; Eli Lilly and Company完全的
-
M.D. Anderson Cancer CenterEli Lilly and Company终止
-
Instituto Nacional de Cancer, BrazilEli Lilly and Company完全的
-
WiSP Wissenschaftlicher Service Pharma GmbHGesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH暂停
-
Fudan University未知
-
Hellenic Oncology Research GroupUniversity Hospital of Crete终止
-
AbbVie (prior sponsor, Abbott)完全的
-
Pusan National University Yangsan HospitalAstraZeneca未知
-
Peking Union Medical College Hospital未知
-
Southwest Oncology GroupNational Cancer Institute (NCI)终止
-
Eli Lilly and Company完全的
-
Barbara Ann Karmanos Cancer Institute撤销
-
Eli Lilly and Company完全的
-
Veeda OncologyEli Lilly and Company; Sanofi; Genentech, Inc.完全的
-
Asan Medical CenterEli Lilly and Company; Korean Cancer Study Group未知
-
Eli Lilly and Company完全的乳腺癌西班牙, 意大利, 俄罗斯联邦, 德国
-
Accelerated Community Oncology Research NetworkEli Lilly and Company; Genentech, Inc.完全的
-
Sun Yat-sen UniversityEli Lilly and Company完全的
-
Eli Lilly and Company完全的
-
Eli Lilly and Company完全的非鳞状组织学的局部晚期或转移性 NSCLC 的组织学或细胞学诊断,且不适合治愈性治疗。匈牙利, 德国, 奥地利, 西班牙, 瑞典